<i>IGF2BP1</i> Harbors Prognostic Significance by Gene Gain and Diverse Expression in Neuroblastoma

Abstract

In neuroblastoma, IGF2BP1 was expressed in the majority of neuroblastoma specimens analyzed and was associated with lower overall patient survival and MYCN abundance. These data demonstrate that IGF2BP1 is a potential oncogene and an independent negative prognostic factor in neuroblastoma.